BTG3 and nasopharyngeal carcinoma: Transactivated MIR106A-5p exerts the effect of macroautophagy/autophagy inhibitors by targeting BTG3 (BTG anti-proliferative factor 3) and activating autophagy to regulate MAPK signaling, thereby promoting the malignant phenotype of NPC (92).